세계의 공황발작 치료 시장 : 약제 클래스별, 투여 경로별, 유통 채널별, 지역별
Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography
상품코드
:
1741531
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
공황발작 치료 시장은 2025년 29억 2,000만 달러, 2032년에는 86억 6,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 16.8%를 나타낼 전망입니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024 |
2025년 시장 규모 |
29억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
16.80% |
2032년 가치 예측 |
86억 6,000만 달러 |
공황발작은 갑작스러운 공포와 고통의 극심한 에피소드로, 경험한 사람은 쇠약해질 수 있습니다. 이러한 발작은 종종 예고 없이 발생하며, 심계항진, 호흡곤란, 가슴통증과 같은 신체적 증상을 유발할 수 있습니다. 공황발작 치료는 증상을 완화하고 발작 빈도를 줄이며 전반적인 삶의 질을 개선하는 데 중점을 둡니다.
시장 역학:
공황발작 치료 시장은 향후 몇 년 동안 큰 성장이 예상됩니다. 세계 시장은 전 세계 공황장애 유병률 증가 등 여러 요인에 의해 주도되고 있습니다. 또한, 정신건강에 대한 인식 증가와 공황발작에 대한 수용과 이해의 확대도 시장 성장에 기여하고 있습니다. 또한, 의료 기술 및 치료 중재의 발전으로 공황장애에 대한 보다 효과적인 치료법이 개발되고 있습니다.
그러나 시장 성장을 억제하는 요인도 있습니다. 이 시장의 주요 과제 중 하나는 공황발작을 포함한 정신 건강 문제와 관련된 낙인입니다. 이러한 낙인은 종종 개인이 도움이나 치료를 받는 것을 방해합니다. 또한, 공황발작 치료의 높은 비용과 일부 지역에서는 불충분한 상환 정책도 시장 성장의 잠재적 장벽으로 작용하고 있습니다.
이러한 어려움에도 불구하고, 시장에는 몇 가지 기회가 존재합니다. 공황발작을 효과적으로 관리할 수 있는 맞춤형 표적치료에 대한 수요가 증가하고 있습니다. 또한, 공황발작 치료에 가상현실 기술과 인공지능의 통합은 시장 확대의 새로운 길을 열어줄 것으로 기대됩니다. 또한, 제약업계의 주요 기업들의 R&D 활동에 대한 투자 증가는 이 시장의 기술 혁신을 촉진하고 성장 기회를 창출할 것으로 보입니다.
본 조사의 주요 특징
- 세계의 공황발작 치료제 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR) 등의 정보를 정리하여 전해드립니다.
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향 및 촉진요인, 지역 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 공황 발작 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 업계 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 공황발작 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이익을 얻고 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매 및 승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
제4장 세계의 공황발작 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 세계의 공황발작 치료 시장, 약제 클래스별, 2020년-2032년
제6장 세계의 공황발작 치료 시장, 투여 경로별, 2020년-2032년
제7장 세계의 공황발작 치료 시장, 유통 채널별, 2020년-2032년
제8장 세계의 공황발작 치료 시장, 지역별, 2020년-2032년
- 북미
- 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- GlaxoSmithKline plc.
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S
제10장 섹션
LSH
영문 목차
Panic Attack Treatment Market is estimated to be valued at USD 2.92 Bn in 2025 and is expected to reach USD 8.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.8% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 2.92 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
16.80% |
2032 Value Projection: |
USD 8.66 Bn |
Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.
Market Dynamics:
The Panic Attack Treatment market is expected to witness significant growth in the coming years. The global market is driven by several factors, including the increasing prevalence of panic disorders worldwide. The rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, is also contributing to market growth. Additionally, advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks.
However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues, including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to market growth.
Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Additionally, the increasing investments in research and development activities by key players in the pharmaceutical industry are likely to drive innovation in this market and create growth opportunities.
Key Features of the Study:
- This report provides in-depth analysis of the global Panic Attack Treatment market, including market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- Key players in the global Panic Attack Treatment market, such as GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S, are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies.
- Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
- The global Panic Attack Treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry.
- Stakeholders can benefit from various strategy matrices used in analyzing the global Panic Attack Treatment market, which would facilitate ease in decision-making.
Global Panic Attack Treatment Market Segmentation:
- By Drug Class
- Antidepressants
- SSRIs
- SNRIs
- TCAs
- MAOIs
- Others
- Anti-anxiety Drugs
- Benzodiazepines
- Beta Blockers
- CGRP Antagonists
- Others
- By Route of Administration
- Oral
- Intravenous
- Intramuscular
- Sublingual
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- GlaxoSmithKline plc
- F.Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of anxiety and panic disorders
- Side effects and safety issues with medications
- Growing use of telemedicine and e-therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Panic Attack Treatment Market, By Drug Class, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Anti-anxiety Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- CGRP Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Panic Attack Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Panic Attack Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Panic Attack Treatment Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lundbeck A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
